Page last updated: 2024-10-31

metoclopramide and Hemangiopericytoma

metoclopramide has been researched along with Hemangiopericytoma in 1 studies

Metoclopramide: A dopamine D2 antagonist that is used as an antiemetic.
metoclopramide : A member of the class of benzamides resulting from the formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with the primary amino group of N,N-diethylethane-1,2-diamine.

Hemangiopericytoma: A tumor composed of spindle cells with a rich vascular network, which apparently arises from pericytes, cells of smooth muscle origin that lie around small vessels. Benign and malignant hemangiopericytomas exist, and the rarity of these lesions has led to considerable confusion in distinguishing between benign and malignant variants. (From Dorland, 27th ed; DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1364)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tochner, ZA1
Kinsella, TJ1
Glatstein, E1

Other Studies

1 other study available for metoclopramide and Hemangiopericytoma

ArticleYear
Hepatic irradiation in the management of metastatic hormone-secreting tumors.
    Cancer, 1985, Jul-01, Volume: 56, Issue:1

    Topics: Adenoma, Islet Cell; Adult; Diarrhea; Female; Hemangiopericytoma; Humans; Laparotomy; Liver Neoplasm

1985